Journal articleEur J Clin Invest2016
Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes.
- Journal
- Eur J Clin Invest
- Published
- 17 December 2015
- Citations
- 31
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background The risk of pancreatic cancer associated with incretin-based therapies is controversial. Methods This study retrospectively analysed the National Health Insurance database including patients with newly diagnosed type 2 diabetes mellitus at an age ≥ 25 years between 1999 and 2010. … Excerpt only: this text is the publisher’s. Read it in full at the source.